iShares Neuroscience and Healthcare ETF IBRN
35.12 USD +0.33 (+0.95%)
Nov 11, 2026, 12:40 PM EST
34.87 Day range 35.12
28.85 52-week range 43.01
- YTD
- +8.66%
- 1 year
- +20.81%
News
benzinga.com PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity' PTC Therapeutics plans to acquire Sangamo’s ST-920 Fabry disease program for $111 million upfront, with FDA filing expected in Q4 2026.
benzinga.com Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
benzinga.com Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves expected to reach $489 million.